Your browser doesn't support javascript.
loading
CD70 defines a subset of proinflammatory and CNS-pathogenic TH1/TH17 lymphocytes and is overexpressed in multiple sclerosis.
Dhaeze, Tessa; Tremblay, Laurence; Lachance, Catherine; Peelen, Evelyn; Zandee, Stephanie; Grasmuck, Camille; Bourbonnière, Lyne; Larouche, Sandra; Ayrignac, Xavier; Rébillard, Rose-Marie; Poirier, Josée; Lahav, Boaz; Duquette, Pierre; Girard, Marc; Moumdjian, Robert; Bouthillier, Alain; Larochelle, Catherine; Prat, Alexandre.
Afiliação
  • Dhaeze T; Department of Neuroscience, Faculty of Medicine, Université de Montréal, and Centre de Recherche du CHUM (CRCHUM), Montréal, QC, H2X0A9, Canada.
  • Tremblay L; Department of Neuroscience, Faculty of Medicine, Université de Montréal, and Centre de Recherche du CHUM (CRCHUM), Montréal, QC, H2X0A9, Canada.
  • Lachance C; Department of Neuroscience, Faculty of Medicine, Université de Montréal, and Centre de Recherche du CHUM (CRCHUM), Montréal, QC, H2X0A9, Canada.
  • Peelen E; Department of Neuroscience, Faculty of Medicine, Université de Montréal, and Centre de Recherche du CHUM (CRCHUM), Montréal, QC, H2X0A9, Canada.
  • Zandee S; Department of Neuroscience, Faculty of Medicine, Université de Montréal, and Centre de Recherche du CHUM (CRCHUM), Montréal, QC, H2X0A9, Canada.
  • Grasmuck C; Department of Neuroscience, Faculty of Medicine, Université de Montréal, and Centre de Recherche du CHUM (CRCHUM), Montréal, QC, H2X0A9, Canada.
  • Bourbonnière L; Department of Neuroscience, Faculty of Medicine, Université de Montréal, and Centre de Recherche du CHUM (CRCHUM), Montréal, QC, H2X0A9, Canada.
  • Larouche S; Department of Neuroscience, Faculty of Medicine, Université de Montréal, and Centre de Recherche du CHUM (CRCHUM), Montréal, QC, H2X0A9, Canada.
  • Ayrignac X; Department of Neuroscience, Faculty of Medicine, Université de Montréal, and Centre de Recherche du CHUM (CRCHUM), Montréal, QC, H2X0A9, Canada.
  • Rébillard RM; Multiple Sclerosis Clinic, Division of Neurology, CHUM, Montréal, QC, H2X0A9, Canada.
  • Poirier J; Department of Neuroscience, Faculty of Medicine, Université de Montréal, and Centre de Recherche du CHUM (CRCHUM), Montréal, QC, H2X0A9, Canada.
  • Lahav B; Multiple Sclerosis Clinic, Division of Neurology, CHUM, Montréal, QC, H2X0A9, Canada.
  • Duquette P; Multiple Sclerosis Clinic, Division of Neurology, CHUM, Montréal, QC, H2X0A9, Canada.
  • Girard M; Department of Neuroscience, Faculty of Medicine, Université de Montréal, and Centre de Recherche du CHUM (CRCHUM), Montréal, QC, H2X0A9, Canada.
  • Moumdjian R; Multiple Sclerosis Clinic, Division of Neurology, CHUM, Montréal, QC, H2X0A9, Canada.
  • Bouthillier A; Department of Neuroscience, Faculty of Medicine, Université de Montréal, and Centre de Recherche du CHUM (CRCHUM), Montréal, QC, H2X0A9, Canada.
  • Larochelle C; Multiple Sclerosis Clinic, Division of Neurology, CHUM, Montréal, QC, H2X0A9, Canada.
  • Prat A; Division of Neurosurgery, CHUM, Montréal, QC, H2X0A9, Canada.
Cell Mol Immunol ; 16(7): 652-665, 2019 07.
Article em En | MEDLINE | ID: mdl-30635649

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistema Nervoso Central / Células Th1 / Encefalomielite Autoimune Experimental / Ligante CD27 / Células Th17 / Esclerose Múltipla Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Cell Mol Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Canadá

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sistema Nervoso Central / Células Th1 / Encefalomielite Autoimune Experimental / Ligante CD27 / Células Th17 / Esclerose Múltipla Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Cell Mol Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Canadá